Leveraging technology intelligently can make the patient-doctor interaction much more seamless and connected, said Samyukta Mullangi, MD, MBA, medical director of oncology at Thyme Care, medical oncologist at Tennessee Oncology.
Samyukta Mullangi, MD, MBA, medical director of oncology at Thyme Care, medical oncologist at Tennessee Oncology, highlights the key points from the first panel of the 2023 Patient-Centered Oncology Care® (PCOC) meeting, “Building Trust: Tools and Strategies for Patient Engagement.”
Transcript
What were some of the major points discussed in your panel on building patient trust and engagement?
Some of the things that we talked about today [were], how do you engender patient trust in an oncology context? How do you assure that you're meeting the needs of a culturally diverse population? And how do you either match the health care workforce to reflect those demographics or use other strategies and tools to try and meet those types of needs? How do you stay connected outside of just that brief clinic encounter and what are ways in which technology can extend the reach of a clinic visit by engaging patients on a more continuous basis between visits as a way to build trust and effective patient engagement? And what are shortcomings of a technology-based solution and how are ways in which humans can be a part of that such that this is truly a dynamic solution that can cater to a wide demographic, not all of whom are very tech savvy?
With the different perspectives of each panelist, was there anything that came out of the conversation that surprised you?
I think we heard some really diverse perspectives, because we had somebody from American Oncology Network, which is a large provider practice, we had somebody from Anthem, which is a health insurer, and then myself representing both a provider as well as a technology-based startup.
I think something that kind of surprised me actually was that we spoke a fair bit about solutions that did not necessarily leverage technology, and I think it just shows that no matter how more digitally enabled health care becomes, there's still such a human component to it. All of our solutions and strategies really kind of based that encounter on a patient interacting with a person, and I think that's probably the right thing to keep that in mind as sort of the heart and soul of medicine.
But I am biased, I do think that technology can really augment and potentiate that encounter, so that was hopefully something that I brought to the table, which is that emphasis that we can really make it a much more seamless, connected encounter by leveraging technology intelligently.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More